Can you provide the average price target for EQUIFAX INC stock?
29 analysts have analysed EFX and the average price target is 240.88 USD. This implies a price increase of 31.06% is expected in the next year compared to the current price of 183.79.
NYSE:EFX • US2944291051
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EQUIFAX INC (EFX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-05 | Needham | Maintains | Buy -> Buy |
| 2026-02-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-05 | Stifel | Maintains | Buy -> Buy |
| 2026-02-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-08 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-10-22 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-10-22 | Stifel | Maintains | Buy -> Buy |
| 2025-10-21 | Needham | Reiterate | Buy -> Buy |
| 2025-10-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-08 | Needham | Reiterate | Buy -> Buy |
| 2025-10-03 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-01 | Seaport Global | Initiate | Neutral |
| 2025-09-15 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-07-23 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.265B 2.79% | 5.681B 7.90% | 6.075B 6.92% | 6.831B 12.45% | 7.473B 9.40% | 8.173B 9.37% | 8.848B 8.26% | 9.648B 9.04% | |
| EBITDA YoY % growth | 1.591B -3.49% | 1.771B 11.29% | 1.872B 5.72% | 2.182B 16.56% | 2.464B 12.92% | 2.778B 12.74% | 3.019B 8.68% | 3.336B 10.50% | |
| EBIT YoY % growth | 971.2M -10.07% | 1.09B 12.24% | 1.145B 5.05% | 1.477B 28.98% | 1.725B 16.79% | 2.067B 19.83% | 2.176B 5.27% | 2.737B 25.78% | |
| Operating Margin | 18.45% | 19.19% | 18.85% | 21.62% | 23.08% | 25.29% | 24.59% | 28.37% | |
| EPS YoY % growth | 6.71 -11.24% | 7.29 8.64% | 7.66 5.08% | 8.75 14.20% | 10.47 19.72% | 12.67 20.98% | 14.12 11.48% | 16.41 16.21% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.71 11.72% | 2.29 14.41% | 2.29 12.36% | 2.38 14.03% | 2.22 29.66% | 2.69 17.41% | 2.69 17.27% | 2.79 17.21% |
| Revenue Q2Q % growth | 1.63B 13.04% | 1.72B 11.91% | 1.688B 9.26% | 1.674B 7.96% | 1.709B 4.85% | 1.822B 5.93% | 1.832B 8.53% | 1.816B 8.48% |
| EBITDA Q2Q % growth | 464.96M 12.42% | 562.35M -16.20% | 567.75M -33.13% | 579.74M -42.66% | 543.9M 16.98% | 621.3M 10.48% | 625.13M 10.11% | 628.41M 8.40% |
| EBIT Q2Q % growth | 294.33M 24.09% | 384.72M 21.98% | 386.82M 25.51% | 402.26M 41.54% | 363.62M 23.54% | 438.62M 14.01% | 434.77M 12.40% | 452.38M 12.46% |
All data in USD
29 analysts have analysed EFX and the average price target is 240.88 USD. This implies a price increase of 31.06% is expected in the next year compared to the current price of 183.79.
EQUIFAX INC (EFX) will report earnings on 2026-04-20, after the market close.
The consensus EPS estimate for the next earnings of EQUIFAX INC (EFX) is 1.71 USD and the consensus revenue estimate is 1.63B USD.
The number of analysts covering EQUIFAX INC (EFX) is 29.